The aim of our study is to evaluate the effect of coffee consumption on the risk of severe liver fibrosis in French patients with NASH.
Study Type
OBSERVATIONAL
Enrollment
107
Centre Hospitalier de Béziers
Béziers, France
Centre hospitalier Métropole Savoie
Chambéry, France
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France
To compare coffee caffeine consumption in NASH patients with early (F1-2) vs advanced (F3-4) liver fibrosis in univariate analysis and after adjustment for potential confounding factors.
Time frame: Day 0
Evaluation of the correlation between the degree of hepatic fibrosis assessed by elastometry (FibroScan) or the histological stage and the caffeine consumption from coffee in univariate analysis and after adjustment for potential confounding factors.
Time frame: Day 0
Comparison of the percentage of regular coffee drinkers in NASH patients with early (F1-2) vs advanced (F3-4) liver fibrosis in univariate analysis and after adjustment for potential confounding factors.
Time frame: Day 0
Comparison of total caffeine consumption from all types of drinks in patients with NASH with early (F1-2) vs advanced (F3-4) liver fibrosis in univariate analysis and after adjustment for potential confounding factors.
Time frame: Day 0
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Groupe Hospitalier Public Sud Oise
Creil, France
Centre Hospitalier Intercommunal de Créteil
Créteil, France
Centre Hospitalier de Gonesse
Gonesse, France
Centre Hospitalier de Hyères
Hyères, France
Centre Hospitalier Départemental Vendée
La Roche-sur-Yon, France
Centre Hospitalier de Bretagne Sud
Lorient, France
Hôpital de Melun
Melun, France
...and 6 more locations